Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Indian Pediatrics
|
November 22, 2000
Pyoderma gangrenosum
M D Ravi, N Sanju
Indian Journal of Pediatrics
|
March 25, 2014
Vaccination Related Pain: Comparison of Two Injection Techniques
G N Girish, M D Ravi
Hospital Pharmacy
|
September 25, 2024
Chronic Immune Thrombocytopenia Purpura Following COVID-19 Vaccination (ChAdOx1 -nCov-19): A Case Report With OneYear Follow-Up
Merrin Mathew, Rovin M Theempalangad, Juny Sebastian, et al.
Intractable & Rare Diseases Research
|
August 27, 2020
Comprehensive Rare Disease Care model for screening and diagnosis of rare genetic diseases - an experience of private medical college and hospital, South India
Sathish Raju Nilakantam, Deepa Bhat, M D Ravi, et al.
Vaccine: X
|
July 28, 2022
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
S Mangarule, S Palkar, M Mitra, et al.
Vaccine: X
|
April 25, 2022
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
S Mangarule, S Palkar, M Mitra, et al.
Vaccine
|
July 24, 2019
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study
Sai Krishna Susarla, Madhu Gupta, Mukta Mantan, et al.
Vaccine
|
September 20, 2024
A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers
Hitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Vaccine
|
September 4, 2023
Immunogenicity and safety of Havisure<sup>TM</sup> vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
Sai Krishna Susarla, Madhu Gupta, Kheya Ghosh Uttam, et al.
Vaccine
|
August 6, 2014
A multicenter prospective hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children less than five years of age in India
T Saluja, S D Sharma, M Gupta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Indian Pediatrics
|
November 22, 2000
Pyoderma gangrenosum
M D Ravi, N Sanju
Indian Journal of Pediatrics
|
March 25, 2014
Vaccination Related Pain: Comparison of Two Injection Techniques
G N Girish, M D Ravi
Hospital Pharmacy
|
September 25, 2024
Chronic Immune Thrombocytopenia Purpura Following COVID-19 Vaccination (ChAdOx1 -nCov-19): A Case Report With OneYear Follow-Up
Merrin Mathew, Rovin M Theempalangad, Juny Sebastian, et al.
Intractable & Rare Diseases Research
|
August 27, 2020
Comprehensive Rare Disease Care model for screening and diagnosis of rare genetic diseases - an experience of private medical college and hospital, South India
Sathish Raju Nilakantam, Deepa Bhat, M D Ravi, et al.
Vaccine: X
|
July 28, 2022
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
S Mangarule, S Palkar, M Mitra, et al.
Vaccine: X
|
April 25, 2022
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
S Mangarule, S Palkar, M Mitra, et al.
Vaccine
|
July 24, 2019
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study
Sai Krishna Susarla, Madhu Gupta, Mukta Mantan, et al.
Vaccine
|
September 20, 2024
A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers
Hitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Vaccine
|
September 4, 2023
Immunogenicity and safety of Havisure<sup>TM</sup> vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
Sai Krishna Susarla, Madhu Gupta, Kheya Ghosh Uttam, et al.
Vaccine
|
August 6, 2014
A multicenter prospective hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children less than five years of age in India
T Saluja, S D Sharma, M Gupta, et al.
Page
of 2